
Ordering Information
| Product Name | Catalog # | UNIT | Price | Qty | FAVORITES | |
NELF CRISPR/Cas9 KO Plasmid (m) | sc-437310 | 20 µg | $397.00 |
Nsmf encodes NELF (nasal embryonic LHRH factor), a guidance-associated protein implicated in neuronal migration and axon pathfinding during development. In mouse, NELF is linked to processes that coordinate neurite outgrowth, olfactory/vomeronasal system development, and the establishment of hypothalamic neuroendocrine circuits. Altered NSMF/NELF function has been associated with congenital hypogonadotropic hypogonadism and Kallmann syndrome–related phenotypes, reflecting roles in GnRH neuron development and reproductive axis regulation. These features make Nsmf a useful target for studying developmental neurobiology, neuroendocrine signaling, and genotype–phenotype relationships in neuronal differentiation models.
NELF CRISPR/Cas9 KO Plasmid (m) is a pool of plasmids designed for targeted disruption of the Nsmf gene in mouse cell lines. Each plasmid co-expresses a unique single guide RNA (sgRNA) targeting a distinct site within the Nsmf together with the Streptococcus pyogenes Cas9 nuclease. The plasmids also encode GFP, allowing fluorescent identification and enrichment of successfully transfected cells by fluorescence microscopy or flow cytometry.
The multi-guide design increases the likelihood of generating insertions or deletions (indels) that disrupt the Nsmf open reading frame following Cas9-mediated double-strand break formation. DNA breaks introduced by the CRISPR/Cas9 system are repaired through endogenous non-homologous end joining (NHEJ) pathways, frequently resulting in frameshift mutations that abolish NELF protein expression.
This CRISPR knockout system enables efficient generation of Nsmf-deficient cell models for investigation of NELF signaling, functional genomics studies, cancer biology research, and evaluation of therapeutic responses in human cell lines.
CRISPRs +/- HDRs
For Research Use Only. Not Intended for Diagnostic or Therapeutic Use.